COVID-19 Vaccine Janssen: assessment of very rare cases of unusual blood clots with low platelets continues

As announced last week, EMA’s safety committee (PRAC) is reviewing very rare cases of unusual blood clots that occurred in the United States following the use of Janssen’s COVID-19 vaccine. The type of blood clot reported, cerebral venous sinus thrombosis (CVST), occurred in most cases in combination with low levels of blood platelets (thrombocytopenia).

Results of the March 2021 survey on credit terms and conditions in euro-denominated securities financing and over-the-counter derivatives markets (SESFOD)

Credit terms and conditions slightly eased for all counterparty types except hedge funds, while hedge fund use of financial leverage increased Maximum maturity of funding increased for many types of collateral, while haircuts and financing rates/spreads decreased for funding secured by all types of collateral Demand for funding continued to weaken across all collateral types […]